Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
about
Generation of Tolerogenic Dendritic Cells and Their Therapeutic ApplicationsRole of the PD-1 pathway in the immune responseImmunoregulation in Fungal DiseasesCutting edge: A monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse modelsBoth PD-1 ligands protect the kidney from ischemia reperfusion injury.Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection.Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter.Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.PD-1, gender, and autoimmunity.Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway.Intranasal peptide-induced tolerance and linked suppression: consequences of complement deficiencyB7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function.Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in miceViral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay.Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice.Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment.Hepatic stellate cells: central modulators of hepatic carcinogenesis.Molecular mechanisms of induction of antigen-specific allograft tolerance by intranasal peptide administration.HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).Up-regulated S100 calcium binding protein A8 in Plasmodium-infected patients correlates with CD4(+)CD25(+)Foxp3 regulatory T cell generation.B7 family molecules as regulators of the maternal immune system in pregnancyHTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory ReceptorsA novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke.The programmed death-1 and interleukin-10 pathways play a down-modulatory role in LP-BM5 retrovirus-induced murine immunodeficiency syndrome.Signaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies.Dendritic cells: a critical player in cancer therapy?The complex role of B7 molecules in tumor immunologyInduction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosusSoluble programmed cell death receptor-1 (sPD-1): a potential biomarker with anti-inflammatory properties in human and experimental acute respiratory distress syndrome (ARDS).Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4+ T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen.Role of dendritic cells in the induction of regulatory T cells.Therapeutic targeting of B7-H1 in breast cancer.Tumor-associated macrophages: from mechanisms to therapy.Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke.Harnessing the properties of dendritic cells in the pursuit of immunological tolerance.Dendritic cells as gatekeepers of tolerance.Immunoregulatory functions of VISTA.The function of myeloid dendritic cells in rheumatoid arthritis.Soluble CD200 Correlates With Interleukin-6 Levels in Sera of COPD Patients: Potential Implication of the CD200/CD200R Axis in the Disease Course.PD-L2 negatively regulates Th1-mediated immunopathology during Fasciola hepatica infection.
P2860
Q26764855-A5A89565-C606-4E3D-8473-219E4AE4D960Q26828748-FB0B652F-97E0-45B3-8463-010AE3A1A60BQ28074776-9BAAF844-8A5A-4132-B973-EC957789CDBCQ28592282-62D7A440-5125-465C-A2AF-7DF1BFD11AEBQ30301290-E2439FA7-0AFF-42BF-88FA-C7279774034FQ30417431-267C8225-69A2-439D-B793-78E761AB1BBCQ33601667-C0CD455F-479D-46F6-8008-46A7C5FCE94AQ33685495-92161EB9-5EEC-4AF6-B159-7CFE40EC361CQ33910421-E60F6841-EC18-4F70-BCE2-970407524100Q34589567-FE7E57A2-7790-4052-88B6-B39463C0001EQ34691304-D203F2E5-6167-43CA-B161-6A12025287D3Q34788681-BA064275-3E7E-4806-8235-781650FA04ADQ35094493-5F133E6C-7C13-4152-98F6-AE8D0B100565Q35102253-CF1EA5BD-8FDC-4934-8749-BCC6A162D487Q35137584-C18FEF03-0FDE-4B1B-9FE1-686FEB8A27CCQ35151883-CC83959C-1E69-4D16-9394-081864EEA0CBQ35642468-FE13E63F-CD6C-41CE-BFB7-0B10C922503EQ35875231-EE708AB6-6C35-45EB-8CE7-0F57C830E654Q35886890-03F1976F-77DD-471B-BC8D-D2FC34652E59Q36126345-958E91B1-3E73-44F2-9F73-A2A72112E7F8Q36185034-34985501-EFDB-4619-8C1C-02BE68432AF5Q36238411-CF8C0B52-D999-457C-9B21-5872E52E645AQ36408695-6D54753E-2E24-4E02-8487-9773459FB714Q36483852-B0E168E4-8824-476B-8179-F8AEA614772CQ36522770-16593A4E-0B36-4F3B-9F80-F4A4D3E86C10Q37276138-2FC42626-7890-48B4-9BCC-1F777861E2FFQ37304913-26484E4E-8D79-4847-9CE1-B37FA0688972Q37316252-CF6DFBFC-FE43-46D6-A89A-662D0CD37FFBQ37410422-C961229F-FACC-443F-9408-AB7B60C088AFQ37740679-C6E57D92-319D-4F1F-85E2-683B60144185Q37895356-16D8C0A9-88A0-4669-8BCF-B66D868F3F17Q37922793-25479D35-BA45-4341-94F9-BC9563DC9C3CQ38230880-00715D22-0B92-46F0-B798-35B7B75FF10EQ38273234-D43021EE-000E-4620-9E64-0D1D66824CA5Q38682156-E2C5CF69-AB3B-4E46-A0A1-AD4ED06E0D9AQ38908238-1309F1D9-E506-4028-90B0-2BCEBA07C505Q38930123-8665A8ED-97DE-4CFE-8DB5-9E29CDB7431FQ39150111-37745D15-4E3B-463A-AF8D-3645553594CEQ39172891-B5740D50-0DB2-4045-A0EC-FAE8B3D693CBQ39247154-1659C794-CFD4-4CAF-80C6-90452A95A0CE
P2860
Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.
@ast
Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.
@en
Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.
@nl
type
label
Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.
@ast
Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.
@en
Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.
@nl
prefLabel
Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.
@ast
Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.
@en
Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.
@nl
P2093
P2860
P356
P1476
Contribution of the PD-1 ligan ...... diated CD4+ T cell activation.
@en
P2093
Anthony J Coyle
Bart N Lambrecht
Daniëlle Hijdra
Femke Muskens
Friso B J van Assema
Harmjan Kuipers
Henk C Hoogsteden
Monique Willart
P2860
P304
P356
10.1002/EJI.200635978
P407
P577
2006-09-01T00:00:00Z